Role of soluble biomarkers in treating multiple sclerosis and neuroinflammatory conditions
Multiple sclerosis (MS) is a complex, chronic immune-mediated disease characterized by acute and progressive inflammatory damage of the central nervous system. MS manifests clinically with unpredictable neurological symptoms from focal inflammatory attacks as well as gradual neurodegeneration which...
Saved in:
| Main Authors: | Gauruv Bose, Simon D.X. Thebault, Giulia Fadda, John A. Brooks, Mark S. Freedman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Neurotherapeutics |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1878747925000662 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neurodegenerative Biomarkers in Multiple Sclerosis: At the Interface Between Research and Clinical Practice
by: Alin Ciubotaru, et al.
Published: (2025-05-01) -
Serum neurofilament heavy chains as a biomarker of neuronal damage in multiple sclerosis relapse
by: P. Beliaziūnas, et al.
Published: (2021-03-01) -
Comparative analysis of neuroinflammatory pathways in Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis: insights into similarities and distinctions
by: Julia Doroszkiewicz, et al.
Published: (2025-04-01) -
Longitudinal Changes in Neuroaxonal and Inflammatory CSF Biomarkers in Multiple Sclerosis Patients Undergoing Interferon Beta Therapy
by: Simona Petrescu, et al.
Published: (2025-06-01) -
The Association of Axonal Damage Biomarkers and Osteopontin at Diagnosis Could Be Useful in Newly Diagnosed MS Patients
by: Eleonora Virgilio, et al.
Published: (2025-07-01)